Skip to main content
Log in

Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Budesonide, a corticosteroid used in the treatment of asthma and allergic reactions, is almost entirely cleared by metabolism in man. We describe the sulphation of budesonide in human liver and lung and provide evidences that the sulphation of budesonide is catalysed by testosterone sulphotransferase. A rapid and reproducible radiometric assay for budesonide sulphotransferase is described. Liver specimens were obtained from 35 men and 65 women and lung specimens from 2 women and 17 men.

The average hepatic budesonide sulphation rate was significantly higher in men (41.1 pmol·min−1·ml−1) than women (28.2 pmol·min−1·mg−1). In the lung, the mean budesonide sulphation rate was 5.0 pmol·min−1·mg−1.

Testosterone strongly inhibited the hepatic sulphation of budesonide, whereas p-nitrophenol and dopamine were poor inhibitors; the IC50 was 7.0 uM (testosterone), 320 uM (p-nitrophenol) and 510 uM (dopamine). The hepatic rates of testosterone, p-nitrophenol and dopamine sulphation were measured in the same samples assayed for budesonide sulphotransferase. There was a correlation between the hepatic rates of budesonide and testosterone sulphation (P<0.001; r=0.810). The activity of testosterone sulphotransferase was significantly greater in men than women (22.0 vs. 17.2 pmol·min−1·mg−1), wheres those of dopamine and p-nitrophenol sulphotransferase were not sex dependent.

The hepatic activity of budesonide sulphotransferase parallels that of testosterone suggesting that sulphation is an important reaction in the metabolism of budesonide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adams JB, McDonald D (1981) Enzymatic synthesis of steroid sulphates. Biochim Biophys Acta 664: 460–468

    Google Scholar 

  • Anderson RJ, Weinshilboum RM (1980) Phenolsulpho-transferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clin Chim Acta 103: 79–90

    Google Scholar 

  • Andersson P, Brattsand R, Edsbacker S, Kallstrom L, Ryrfeldt A (1982) Biotransformation rate (in vitro) and systemic potency (in vivo) of the topical corticosteroid budesonide in male and female rats. J Steroid Biochem 17: 703–706

    Google Scholar 

  • Andersson P, Ryrfeldt A (1984) Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17a,21-dipropionate in human liver and lung homogenates. J Pharm Pharmacol 36: 763–765

    Google Scholar 

  • Bliss CI (1967) Statistic in biology, vol 1. McGraw-Hill, New York 101–110

    Google Scholar 

  • Brattsand R, Andersson PT, Edsbacker S, Ryrfeldt A (1987) Development of glucocorticosteroids with lung selectivity. In: Ellunc-Micallef R, Lam WK, Toogood JH Advances in the use of inhaled corticosteroids. Excerpta Medica No 58,. pp 60–78

  • Burchell B, Coughtrie MWH (1989) UDP-glucuronosyltransferases. Pharmacol Ther 43: 261–243

    Google Scholar 

  • Cappiello M, Giuliani L, Pacifici GM (1990) Differential distribution of phenol and catechol sulphotransferases in human liver and intestinal mucosa. Pharmacology 40: 69–76

    Google Scholar 

  • Cappiello M, Giuliani L, Pacifici GM (1991) Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus. Dev Pharmacol Ther 16: 83–88

    Google Scholar 

  • Clissold SP, Heel RC (1984) Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis. Drugs 28: 485–518

    Google Scholar 

  • Edsbacker S, Jonsson S, Lindberg C, Ryrfeldt A, Thalen A (1983) Metabolic pathways of the topical glucocorticoid budesonide in man. Drug Metabol Disp 11: 590–596

    Google Scholar 

  • Edsbacker S, Andersson P, Lindberg C, Paulson J, Ryrfeldt A, Thalen A (1987) Liver metabolism of budesonide in rat, mouse, and man. Drug Metab Dispos 15: 403–411

    Google Scholar 

  • Falany CN (1991) Molecular enzymology of human liver cytosolic sulphotransferases. Trends Pharmacol Sci 12: 255–256

    Google Scholar 

  • Foldes A, Meek JL (1973) Rat brain phenolsulfotransferase partial purification and some properties. Biochim Biophys Acta 327: 365–374

    Google Scholar 

  • Haynes RC (1990) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and action of adrenocortical hormones. In: eds Goodman Gilman A, Rall TW, Nies AS, Taylor P The pharmacological basis of therapeutics. Pergamon Press, New York, pp 1431–1462

    Google Scholar 

  • Hernandez JS, Waston RWG, Wood TC, Weinshilboum RM (1992) Sulphation of estrone and 17-estradiol in human liver. Drug Metab Disp 20: 413–422

    Google Scholar 

  • Horwitz JP, Misra RS, Rozhin J, Helmer S, Bhuta A, Brooks SC (1980) Studies on bovine adrenal estrogen sulfotransferase. Biochim Biophys Acta 613: 85–94

    Google Scholar 

  • Irshaid YM, Tephly TR (1987) Isolation and purification of two human liver UDP-glucuronosyltransferases. Molec Pharmacol 31: 27–34

    Google Scholar 

  • Johansson SA, Andersson K-E, Brattsand R, Gruvstad E, Hedner P (1982) Topical and systemic glucocorticoid potencies of budesonide and beclamethasone dipropionate in man. Eur J Clin Pharmacol 22: 523–529

    Google Scholar 

  • Leakey JEA, Hume R, Burchell B (1987) Development of multiple activities of UDP-glucuronyltransefare in human liver. Biochem J 243: 859–861

    Google Scholar 

  • Lewis WG, Witt KR, Singer SS (1981) Enzymatic sulfation of steroids. XIII. Hepatic deoxycorticosterone sulfotransferases in rats, properties and comparison with glucocorticoid sulfotransferases. Proc Soc Exper Biol Med 166: 70–75

    Google Scholar 

  • Lowry NJ, Rosebrough NJ, Farr AL, Randall (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  • Pacifici GM, Back D (1988) Sulphation and glucuronidation of ethinyloestradiol in human liver in vitro. J Steroid Biochem 31: 345–349

    Google Scholar 

  • Pacifici GM, Franchi M, Bencini C, Repetti F, Di Lascio N, Muraro GB (1988a) Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 7: 849–856

    Google Scholar 

  • Pacifici GM, Franchi M, Colizzi C, Giuliani L, Rane A (1988b) Sulphotransferase in humans: Development and tissue distribution. Pharmacology 36: 411–419

    Google Scholar 

  • Pacifici GM, Bigotti R, Marchi G, Giuliani L (1993a) Minoxidil sulphation in human liver and platelets: a study on the interindividual variability. Eur J Clin Pharmacol 45: 337–341

    Google Scholar 

  • Pacifici GM, Marchi G (1993b) Interindividual variability of phenol-and catechol-sulphotransferases in platelets of adult subjects and newborn. Br J Clin Pharmacol 36: 593–597

    Google Scholar 

  • Pacifici GM, Kubrich M, Giuliani L de Vries M, Rane A (1993c) Sulphation and glucuronidation of ritodrine in human and adult tissues. Eur J Clin Pharmacol 44: 259–264

    Google Scholar 

  • Price RA, Cox NJ, Spielman RS, Van Loon JA, Maidak BL, Weinshilboum RM (1988) Inheritance of human platelet thermolabile phenol sulphotransferase (TL PST) activity. Genet Epidemiol 5: 1–15

    Google Scholar 

  • Price RA, Spielman RS, Lucerna AL, Van Loon JA, Maidak BL, Weinshilboum RM (1989) Genetic polymorphism for human platelet thermostable phenol sulphotransferase (TS PST) activity. Genetics 122: 905–914

    Google Scholar 

  • Ryrfeldt A, Andersson P, Edsbacker S, Tonnesson M, Davies D, Pauwles R (1982) Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 63 [Suppl 122]: 86–95

    Google Scholar 

  • Temellini A, Giuliani L, Pacifici GM (1991) Interindividual variability in the glucuronidation and sulphation of ethinyloestradiol in human liver. Br J Clin Pharmacol 31: 661–664

    Google Scholar 

  • Singer SS (1978) Enzymatic sulfation of steroids. IV. Control of the hepatic glucocorticoid sulfotransferase activity and the individual glucocorticoid sulfotransferases from male and female rats by adrenal glands and corticosteroids. Endocrinology 103: 66–73

    Google Scholar 

  • Singer SS, Giera D, Johnson J, Sylvester S (1976) Enzymatic sulfation of steroids. I. The enzymatic basis for the sex difference in cortisol sulphation by rat liver preparations. Endocrinology 98: 963–974

    Google Scholar 

  • Singer SS, Federspiel MJ, Green J, Lewis WG, Martin V, Witt KR, Tappel J (1982) Enzymatic sulfation of steroids. XV. Studies differentiating between rat liver androgen, estrogen, bile acid, glucocorticoid and phenol sulfotransferases. Biochim Biophys Acta 700: 110–117

    Google Scholar 

  • Van Loon J, Weinshilboum RM (1984) Human platelet phenol sulfotransferase: familial variation in thermal stability of TS form. Gen Biochem 22: 997–1014

    Google Scholar 

  • Weinshilboum RM (1986) Phenol sulphotransferases in humans: properties, regulation, and function. Fed Proc 45: 2223–2228

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pacifici, G.M., Ferroni, M.A., Temellini, A. et al. Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase. Eur J Clin Pharmacol 46, 49–54 (1994). https://doi.org/10.1007/BF00195915

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00195915

Key words

Navigation